National Viral Hepatitis Roundtable (NVHR) and NASTAD hosted a two-day virtual convening showcasing promising models and best practices for integrating hepatitis C testing and treatment into key settings.

Day 1 of this convening features sessions on providing HCV care in programs providing medications for opioid use disorder (MOUD) and state correctional facilities.
Day 2 of this convening features sessions on providing HCV care in federally qualified health centers (FQHCs) and syringe services programs (SSPs).

Funding for this meeting is made possible by cooperative agreement #CDC-RFA-PS21-2105, “National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers” award #NU51PS005195” from the Centers for Disease Control and Prevention, Division of Viral Hepatitis. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.